Meet Dr. Claus Roehrborn
Urologist Specializing in Prostate Cancer

Holder of the:
S.T. Harris Family Chair in Medical Science, in Honor of John D. McConnell, M.D.
E.E. Fogelson and Greer Garson Fogelson Distinguished Chair in Urology

Claus Roehrborn, M.D., a urologist with special expertise in prostate cancer, has devoted his career to researching and treating prostate diseases. The greatest reward? “When a patient sends his son, brother, uncle, or father to see me — even from far-away places,” he says. “That tells me the patient thinks there’s no one else he would rather have his family member see.”

I visit with patients. I sit down with them and take their history. I do my own diagnostic evaluation, prostate biopsies, and surgeries. So patients are cared for by me in a very personal manner.”

Among many awards, Dr. Roehrborn is consistently recognized as a Best Doctor by D Magazine and a Super Doctor by Texas Monthly. The Department of Urology at UT Southwestern is nationally ranked in U.S. News & World Report's America's Best Hospitals 2013.

Lots of people put their trust in Dr. Roehrborn. He’s performed more than 1,200 urologic surgeries using advanced robotic techniques that offer patients the fastest possible return of continence and sexual function. That level of expertise is unmatched in North Texas.

“Robotic surgery has added immensely to the quality of outcomes for my patients,” Dr. Roehrborn says. “It combines the best of minimally invasive laparoscopic surgery with 3-D imaging and magnification capabilities that in my experience are unbeatable. It gives patients with prostate problems and diseases a very quick and very early return of both continence and potency.”

An expert in prostate cancer, Dr. Roehrborn maintains a blog where he discusses issues in urology and prostate diseases, including controversies over prostate specific antigen (PSA) testing. He’s also a proponent of active surveillance programs for prostate cancer, rather than immediately commencing treatment whenever it’s found. “Active surveillance is often not chosen by community urologists,” he says. “But oftentimes patients who have been diagnosed with prostate cancer by way of PSA testing have a low stage of the disease and may actually benefit more from surveillance.”

Clinical Interests/Specialties

Prostate Cancer

  • Surgical treatment of prostate cancer
  • Prostate cancer markers


  • Male lower urinary tract symptoms (LUTS)
  • Benign prostatic hyperplasia (BPH)